Conceptus scales back sales outlook, raises cash
This article was originally published in Clinica
Executive Summary
Conceptus, the San Carlos, California-based developer of the Essure minimally invasive female sterilisation procedure, says it will not make its previous 2004 sales projection of $22-24m. The figure is now expected to be about a third lower, at $15-16m.